NCT06366048 A Study on Relationship Between Resected Normal Liver Parenchymal Volume（RNLV）and Post-Hepatectomy Liver Failure (PHLF)
| NCT ID | NCT06366048 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Natural Science Foundation of China |
| Condition | Liver Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,600 participants |
| Start Date | 2022-12-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,600 participants in total. It began in 2022-12-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The post-hepatotectomy liver failure (PHLF) is still the most worrisome complication of hepatic resection. Surgeons have always been making efforts to preoperatively predict PHLF using kinds of techniques, scoring systems, and variables. The investigators of this study tried to create an individual predictive model based on the variable, resected normal parenchymal volume (RNLV), then assessing the performance and value of the model in clinical practice.
Eligibility Criteria
Inclusion criteria: * selective hepatectomies; * histologically confirmed as HCC and ICC * complete and accessible data Exclusion criteria: * any history of Associated Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS) * any history of portal vein embolism (PVE) * any history of tumor rupture * emergency surgery * pathologically diagnosed with neither HCC nor ICC * concomitant resection of gastrointestinal organs, spleenectomy or other organs
Contact & Investigator
Yuan-yuan Wang
STUDY DIRECTOR
Eastern Hepatobiliary Surgery Hospital
Frequently Asked Questions
Who can join the NCT06366048 clinical trial?
This trial is open to participants of all sexes, studying Liver Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06366048 currently recruiting?
Yes, NCT06366048 is actively recruiting participants. Contact the research team at wangyuanyuan702@foxmail.com for enrollment information.
Where is the NCT06366048 trial being conducted?
This trial is being conducted at Fujian, China, Shanhai, China, Shenzhencun, China.
Who is sponsoring the NCT06366048 clinical trial?
NCT06366048 is sponsored by National Natural Science Foundation of China. The principal investigator is Yuan-yuan Wang at Eastern Hepatobiliary Surgery Hospital. The trial plans to enroll 1,600 participants.